D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 116 Citations 55,105 683 World Ranking 141 National Ranking 11
Medicine D-index 144 Citations 86,242 1,058 World Ranking 552 National Ranking 66

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Cancer

His primary areas of study are Internal medicine, Immunology, Lupus erythematosus, Systemic lupus erythematosus and Surgery. Internal medicine is represented through his Rheumatology, Connective tissue disease, Systemic disease, Cohort study and Immunopathology research. The study incorporates disciplines such as Systemic lupus, Disease and Clinical significance in addition to Rheumatology.

His Lupus erythematosus research is multidisciplinary, incorporating perspectives in Randomized controlled trial, Intention-to-treat analysis, Family medicine, Physical therapy and Severity of illness. David A. Isenberg focuses mostly in the field of Systemic lupus erythematosus, narrowing it down to topics relating to Anti-SSA/Ro autoantibodies and, in certain cases, Anti-nuclear antibody. The concepts of his Surgery study are interwoven with issues in Lupus nephritis and Adverse effect.

His most cited work include:

  • Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. (2280 citations)
  • The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. (1673 citations)
  • Systemic lupus erythematosus. (1376 citations)

What are the main themes of his work throughout his whole career to date?

David A. Isenberg mainly investigates Immunology, Internal medicine, Lupus erythematosus, Systemic lupus erythematosus and Antibody. His research on Immunology frequently links to adjacent areas such as Disease. His work deals with themes such as Gastroenterology and Surgery, which intersect with Internal medicine.

As part of the same scientific family, David A. Isenberg usually focuses on Lupus erythematosus, concentrating on Connective tissue disease and intersecting with Systemic disease and Immunopathology. His Systemic lupus erythematosus study incorporates themes from Clinical trial and Discoid lupus erythematosus. He has researched Antibody in several fields, including Molecular biology and Antigen.

He most often published in these fields:

  • Immunology (48.74%)
  • Internal medicine (43.33%)
  • Lupus erythematosus (21.95%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (43.33%)
  • Systemic lupus erythematosus (20.23%)
  • Disease (13.33%)

In recent papers he was focusing on the following fields of study:

David A. Isenberg mainly focuses on Internal medicine, Systemic lupus erythematosus, Disease, Cohort and Rituximab. The various areas that David A. Isenberg examines in his Internal medicine study include Gastroenterology and Lupus erythematosus. His Lupus erythematosus research incorporates elements of Young adult and Severity of illness.

His Systemic lupus erythematosus research is multidisciplinary, incorporating elements of Body mass index and Arthritis. His research integrates issues of Dermatology, Belimumab and Intensive care medicine in his study of Rituximab. His Antibody study is focused on Immunology in general.

Between 2018 and 2021, his most popular works were:

  • New therapies for systemic lupus erythematosus - past imperfect, future tense. (47 citations)
  • A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires. (32 citations)
  • Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort. (29 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Cancer

David A. Isenberg spends much of his time researching Internal medicine, Rituximab, Rheumatology, Systemic lupus erythematosus and Cohort. David A. Isenberg applies his multidisciplinary studies on Internal medicine and In patient in his research. His Rheumatology study also includes

  • Frailty Index and related Systemic lupus,
  • Hazard ratio which is related to area like Proportional hazards model, Criterion validity and Prospective cohort study.

His studies in Systemic lupus erythematosus integrate themes in fields like Cancer research, Tyrosine kinase, Bruton's tyrosine kinase, Immune system and B cell. His Belimumab research is under the purview of Immunology. His research in Immunology is mostly concerned with Avidity.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.

Michelle Petri;Ana Maria Orbai;Graciela S. Alarcõn;Caroline Gordon.
Arthritis & Rheumatism (2012)

3514 Citations

Systemic lupus erythematosus.

Anisur Rahman;David A Isenberg.
The New England Journal of Medicine (2008)

2215 Citations

The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

Dafna Gladman;Ellen Ginzler;Charles Goldsmith;Paul Fortin.
Arthritis & Rheumatism (1996)

2141 Citations

Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

Claudio Vitali;Stefano Bombardieri;Haralampos M. Moutsopoulos;Genesio Balestrieri.
Arthritis & Rheumatism (1993)

1803 Citations

Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy

Michael R. Ehrenstein;Jamie G. Evans;Animesh Singh;Samantha Moore.
Journal of Experimental Medicine (2004)

1537 Citations

CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients

Paul A. Blair;Lina Yassin Noreña;Fabian Flores-Borja;David J. Rawlings.
Immunity (2010)

1453 Citations

Efficacy and Safety of Rituximab in Moderately-to-Severely Active Systemic Lupus Erythematosus: The Randomized, Double-Blind, Phase II/III Systemic Lupus Erythematosus Evaluation of Rituximab Trial

Joan T. Merrill;C. Michael Neuwelt;Daniel J. Wallace;Joseph C. Shanahan.
Arthritis & Rheumatism (2010)

1359 Citations

The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes

Matthew H. Liang;Michael Corzillius;Sang Cheol Bae;Robert A. Lew.
Arthritis & Rheumatism (1999)

1243 Citations

Systemic Lupus Erythematosus

Inam Haq;David A Isenberg.
(2012)

1133 Citations

Mortality in systemic lupus erythematosus.

S. Bernatsky;J. F. Boivin;L. Joseph;S. Manzi.
Arthritis & Rheumatism (2006)

1121 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing David A. Isenberg

Yehuda Shoenfeld

Yehuda Shoenfeld

Sheba Medical Center

Publications: 309

Michelle Petri

Michelle Petri

Johns Hopkins University School of Medicine

Publications: 195

Graciela S. Alarcón

Graciela S. Alarcón

University of Alabama at Birmingham

Publications: 188

Murray B. Urowitz

Murray B. Urowitz

Toronto Western Hospital

Publications: 149

Dafna D. Gladman

Dafna D. Gladman

Toronto Western Hospital

Publications: 140

Ricard Cervera

Ricard Cervera

University of Barcelona

Publications: 135

Andrea Doria

Andrea Doria

University of Padua

Publications: 127

Caroline Gordon

Caroline Gordon

University of Birmingham

Publications: 116

Rosalind Ramsey-Goldman

Rosalind Ramsey-Goldman

Northwestern University

Publications: 109

Haralampos M. Moutsopoulos

Haralampos M. Moutsopoulos

National and Kapodistrian University of Athens

Publications: 105

Iva Gunnarsson

Iva Gunnarsson

Karolinska University Hospital

Publications: 105

Pier Luigi Meroni

Pier Luigi Meroni

Istituto Auxologico Italiano

Publications: 99

Thomas Dörner

Thomas Dörner

Charité - University Medicine Berlin

Publications: 97

Ann E. Clarke

Ann E. Clarke

University of Calgary

Publications: 95

John D. Reveille

John D. Reveille

The University of Texas Health Science Center at Houston

Publications: 93

Angela Tincani

Angela Tincani

University of Brescia

Publications: 91

Trending Scientists

Marco Mellia

Marco Mellia

Polytechnic University of Turin

Robert Kollmann

Robert Kollmann

Université Libre de Bruxelles

William Ribarsky

William Ribarsky

University of North Carolina at Charlotte

Vanessa Wood

Vanessa Wood

ETH Zurich

Paul D. Townsend

Paul D. Townsend

Tyndall National Institute

Wen Liu

Wen Liu

Peking University

Alexander Pines

Alexander Pines

University of California, Berkeley

Kurt W. Kohn

Kurt W. Kohn

National Institutes of Health

Petras P. Dzeja

Petras P. Dzeja

Mayo Clinic

Fabrice Gouilleux

Fabrice Gouilleux

François Rabelais University

Robert M. Bell

Robert M. Bell

Yale University

Patrick W. Stroman

Patrick W. Stroman

Queen's University

David R. Fish

David R. Fish

University College London

Rémy Pujol

Rémy Pujol

Inserm : Institut national de la santé et de la recherche médicale

Gerhard Jahn

Gerhard Jahn

University of Tübingen

John B. Reid

John B. Reid

University of Oregon

Something went wrong. Please try again later.